Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo
about
What is new for an old molecule? Systematic review and recommendations on the use of resveratrolResveratrol in prostate diseases - a short reviewDietary factors and epigenetic regulation for prostate cancer preventionBetter Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and LifespanDietary polyphenols in prevention and treatment of prostate cancerResveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell developmentStilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsA metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.Repressive effects of resveratrol on androgen receptor transcriptional activity.Resveratrol and cancer: focus on in vivo evidence.Apoptosis by dietary agents for prevention and treatment of prostate cancerSubchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.Resveratrol: Biological and pharmaceutical properties as anticancer molecule.Future directions in the prevention of prostate cancer.Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.Resveratrol commonly displays hormesis: occurrence and biomedical significance.Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.Resveratrol: inhibitory effects on metastatic cell behaviors and voltage-gated Na⁺ channel activity in rat prostate cancer in vitro.Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.Transcriptomic alterations in human prostate cancer cell LNCaP tumor xenograft modulated by dietary phenethyl isothiocyanate.Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.ProstaCaid induces G2/M cell cycle arrest and apoptosis in human and mouse androgen-dependent and-independent prostate cancer cells.Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells.Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized.Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies.The Role of Resveratrol in Cancer Therapy.Reversible Toxic Effects of the Dietary Supplement Indole-3-Carbinol in an Immune Compromised Rodent Model: Intestine as the Main Target.Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals.
P2860
Q21089966-9773D744-4CBC-4837-8606-6BDD1BA82BD7Q24601444-D52C6C83-AEA4-4532-8C7B-6F1DD76545ACQ26991774-4FB266EE-4FC8-4978-BDB4-7BFE771F74C7Q28073173-796FADFB-7523-4398-8F53-195A85F4C90AQ28084787-3AAC6C67-4D5E-4B10-9D0A-857C8A620C98Q28483748-AA1640E3-4CF4-4863-992A-43982B0E2412Q28539233-3752AE4A-E70F-43D4-96FC-8650903D6936Q30423585-52CB7CF1-3CC1-4EEE-BEDA-1D2F738F878EQ31156045-34639A8A-8197-44B1-9CB0-78187156F0E8Q33509527-D57523B0-2661-48C4-955A-A7F7BED7BE4EQ33578943-72DEC8D8-504E-4A6E-B350-CEE4055AE24DQ34614042-35F6BF3B-C105-42D6-9A0A-2659C84E0791Q35570811-A72F768E-DCDC-43F2-ABCC-46E0BC0E7D74Q36645457-7F03BAEC-4DB4-46C3-8057-22102394D6A7Q36848141-2D9F8428-86ED-490B-AD9B-B50BD694BA04Q37279094-17A10E61-50B7-4360-ACE3-71C1D5BBBA2AQ37780645-C4709B18-AE91-4780-8847-1EE49BC0894DQ37813307-C0F41D06-640A-4E8D-8E35-C8D337F29399Q38323902-6292D81F-8F2B-4AA3-BA47-5051C739287CQ38365582-895323D3-B3DB-480A-B3C5-915225F70E31Q38584742-7C47904F-6704-4DA6-8696-28C286CEEB92Q38968092-E27BB31F-AB08-4185-88AC-5CFA912C87CDQ39106653-2F74DC10-5984-4058-9CED-1219999619B2Q39401093-C4BC153C-21F5-4F23-9D3A-A2069F5BB767Q39527903-BAD08E1B-E787-44C4-B75C-7A9A81EDAAF0Q39687146-101144B2-C5B9-4B61-A2EE-AD7A3D3CF1F2Q41551014-50B49598-10EE-47E0-86AD-24743279AAA5Q46752370-5DB46988-1672-4A78-B0E3-D5A8623970A9Q47123664-BBFA0659-65FB-4511-99F2-439AB7BA1CB3Q47940580-5874644E-7D73-4347-9B16-C62E35B55B98Q53143172-4EE55D8A-5641-428E-BD1F-E7A63205A6CAQ53251822-CCAFD31E-13FA-4D12-848A-267B712E5F71
P2860
Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential effects of resver ...... cer cells in vitro and in vivo
@en
Differential effects of resver ...... er cells in vitro and in vivo.
@nl
type
label
Differential effects of resver ...... cer cells in vitro and in vivo
@en
Differential effects of resver ...... er cells in vitro and in vivo.
@nl
prefLabel
Differential effects of resver ...... cer cells in vitro and in vivo
@en
Differential effects of resver ...... er cells in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Differential effects of resver ...... cer cells in vitro and in vivo
@en
P2093
Bryan T Vinyard
Connie M Remsberg
Harold Seifried
Neal M Davies
Stephen D Hursting
Susan N Perkins
Tamaro S Hudson
Thomas T Y Wang
Tien-Chung Wang
Yoko Takahashi
P2860
P304
P356
10.1093/CARCIN/BGN131
P407
P577
2008-06-26T00:00:00Z